Oracle Health Sciences

Phone:+1.800.633.0738
https://www.oracle.com
From Oracle Health Sciences
Hcp Title
Solution for Expiry Labels, DtP, and Study Timelines Due to EU 536/2014 Clinical Trials Regulation
Regulation EU No 536/2014 on clinical trials will come many changes that will impact study startup processes and timelines, expiry labeling on primary and secondary packaging, and study administration methods such as direct-to-patient.
Manage Challenges from the EU 536/2014 Clinical Trials Regulation
Page 1 of 1